Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

The glucocorticoid receptor helps protect skin from tumors and other issues.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Immune cells called Treg cells are essential for hair growth and regeneration.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

The skin plays a key role in immune responses and reflects emotional and stress reactions.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.